Galmed Pharmaceuticals Ltd reports results for the quarter ended in December - Earnings Summary

Eocene

29/03/2023 23:08

* Galmed Pharmaceuticals Ltd  GLMD.OQ  reported a quarterly
adjusted loss of 10 cents​​ per share for the quarter ended in
December. The mean expectation of two analysts for the quarter
was for a loss of 14 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Galmed Pharmaceuticals Ltd's reported EPS for the quarter
was a
loss of 10 cents​.
    * The mean earnings estimate of analysts had risen by
about 12.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Galmed Pharmaceuticals Ltd shares had fallen by 14.3% this
quarter.
    * The company reported a quarterly loss of $2.64 million.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 29 at 10:08 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.14          -0.10          Beat
 Sep. 30 2022      -0.16          -0.21          Missed
 Jun. 30 2022      -0.24          -0.15          Beat
 Mar. 31 2022      -0.32          -0.24          Beat